This website is part of the ECDC (European Centre for Disease Prevention and Control) network

Publications and documents

 

 ESAC-Net DOCUMENTS

 
 

 ESAC-Net REPORTS

 
 

 ARCHIVE

 

Articles

 

2012

  • Safrany N, Monnet DL. Antibiotics obtained without a prescription in Europe. Lancet Infect Dis. 2012 Mar;12(3):182-3.   

 

2011

  • Adriaenssens N, Coenen S, Kroes AC, Versporten A, Vankerckhoven V, Muller A, et al. European Surveillance of Antimicrobial Consumption (ESAC): systemic antiviral use in Europe. J Antimicrob Chemother 2011;66(8):1897-905.
  • Adriaenssens N, Coenen S, Tonkin-Crine S, Verheij T, Little P, Goossens H, on behalf of the ESAC Project Group. European Surveillance of Antimicrobial Consumption (ESAC): disease-specific quality indicators for outpatient antibiotic prescribing. BMJ Qual Saf 2011;20(9):764-72.
  • Čižman M, on the behalf of the Slovenian Surveillance of Antimicrobial Consumption Study Group. Nationwide hospital antibiotic consumption in Slovenia.J Antimicrob Chemother 2011;66(9):2189-91.
  • McClean P, Hughes C, Tunney M, Goossens H, Jans B, on the behalf of the ESAC Project Group. European Surveillance of Antimicrobial Consumption (ESAC) Nursing Home Project Group: antimicrobial prescribing in European nursing homes. J Antimicrob Chemother 2011;66(7):1609-16.
  • Zarb P, Amadeo B, Muller A, Drapier N, Vankerckhoven V, Davey P, Goossens H, and on behalf of the ESAC-3 hospital care subproject group. Identification of targets for quality improvement in antimicrobial prescribing: the web-based ESAC Point Prevalence Survey 2009. J Antimicrob Chemother 2011;66(2):443-9.
  • Zarb P, Ansari F, Muller A, Vankerckhoven V, Davey PG, Goossens H. Drug Utilization 75% (DU75%) in 17 European Hospitals (2000 - 2005): Results from the ESAC-2 Hospital Care Sub Project. Curr Clin Pharmacol 2011;6(1):62-70.
  • Zarb P, Goossens H. European Surveillance of Antimicrobial Consumption (ESAC): value of a point-prevalence survey of antimicrobial use across Europe.Drugs 2011;71(6):745-55.


2010

  • Adriaenssens N, Coenen S, Muller A, Vankerckhoven V, Goossens H,  on behalf of the ESAC Project Group. European Surveillance of Antimicrobial Consumption (ESAC): outpatient systemic antimycotic and antifungal use in Europe. J Antimicrob Chemother 2010;65(4):769-74.
  • Aldeyab M, Kearney M, McElnay J, Magee F, Conlon G, Gill D, et al. A point prevalence survey of antibiotic prescriptions: benchmaking and patterns of use.Br J Clin Pharmacol 2011;71(2):293-6.
  • Amadeo B, Zarb P, Muller A, Drapier N, Vankerckhoven V, Rogues A, Davey P, Goossens H. European Surveillance of Antimicrobial Consumption (ESAC) point prevalence survey 2008: paediatric antimicrobial prescribing in 32 hospitals of 21 European countries. J Antimicrob Chemother 2010;65(10):2247-52.
  • Amadeo B, Dumartin C, Parneix P, Fourrier-Réglat A, Rogues AM. Relationship between antibiotic consumption and antibiotic policy: an adjusted analysis in the French healthcare system.J Antimicrob Chemother 2011;66(2):434-42.    
  • Ansari F, Molana H, Goossens H, Davey P, on the behalf of the ESAC II Hospital Care study group. Development of standardized methods for analysis of changes in antibacterial use in hospitals from 18 European countries: the European Surveillance of Antimicrobial Consumption (ESAC) longitudinal survey, 2000-06. J Antimicrob Chemother 2010;65(12):2685-91.


2009

  • Adriaenssens N, Goossens H, Coenen S, on behalf of the ESAC Project Group.Comment on: Developments in outpatient parenteral antimicrobial therapy (OPAT) for Gram-positive infections in Europe, and the potential impact of daptomycin. J Antimicrob Chemother 2009;64(6):1347.
  • Ansari F, Molana H, Goossens H, Davey P. Development of standardised methods for analysis of changes in antibacterial use in hospitals from 18 European countries: the European Surveillance of Antimicrobial Consumption (ESAC) longitudinal survey 2000 to 2006. J Antimicrob Chemother 2010;65(12):2685-91.
  • Coenen S, Muller A, Adriaenssens N, Vankerckhoven V, Hendrickx E, Goossens H. European Surveillance of Antimicrobial Consumption (ESAC): outpatient parenteral antibiotic treatment in Europe. J Antimicrob Chemother 2009;64(1): 200-5. 

2008

  • van de Sande-Bruinsma N, Grundmann H, Verloo D, Tiemersma E, Monen J, Goossens H, et al.. Antimicrobial drug use and resistance in Europe. Emerg Infect Dis 2008;14(11):1722-30.

 
2007    

  • Campos J, Ferech M, Lázaro E, de Abajo F, Oteo J, Stephens P, et al. Surveillance of outpatient antibiotic consumption in Spain according to sales data and reimbursement data. J Antimicrob Chemother 2007;60(3):698-701.
  • Coenen S, Costers M, Goossens H. Comment on: Can mass media campaigns change antimicrobial prescribing? A regional evaluation study. J Antimicrob Chemother 2007;60(1):179-80.
  • Coenen S, Ferech M, Haaijer-Ruskamp FM, Butler CC, Vander Stichele RH, Verheij TJM, et al. European Surveillance of Antimicrobial Consumption (ESAC): quality indicators for outpatient antibiotic use in Europe. Qual Saf Health Care 2007;16(6):440-445.
  • Davey P, Ferech M, Ansari F, Muller A, Goossens H, on behalf of the ESAC Project Group. Outpatient antibiotic use in the four administrations of the UK: cross-sectional and longitudinal analysis. J Antimicrob Chemother 2008;62(6):1441-7. 
  • Elseviers MM, Ferech M, Vander Stichele RH, Goossens H, and the ESAC project group. Antibiotic use in ambulatory care in Europe (ESAC data 1997-2002): trends, regional differences and seasonal fluctuations. Pharmacoepidemiol Drug Saf 2007; 16(1):115-23.
  • Goossens H, Ferech M, Coenen S, Stephens P, and the ESAC Project Group. Comparison of outpatient systemic antibiotic use in 2004 between the United States and 27 European countries. Clin Inf Dis 2007;44(8);1091-5. Erratum in: Clin Infect Dis 2007;44(9):1259.
  • Muller A, Coenen, S, Goossens H, Monnet DL, and the ESAC project group. European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe 1998-2005. Euro Surveill 2007;12(41). pii=3284.


2006

  • Coenen S, Ferech M, Dvorakova K, Hendrickx E, Suetens C, et al. European Surveillance of Antimicrobial Consumption: Outpatient cephalosporin use in Europe. J Antimicrob Chemother 2006;58(2):413-7.
  • Coenen S, Ferech M, Malhotra-Kumar S, Hendrickx E, Suetens C,  Goossens H, et al. European Surveillance of Antimicrobial Consumption: Outpatient macrolide, lincosamide and streptogramin use in Europe.. J Antimicrob Chemother 2006;58(2): 418-22.
  • Ferech M, Andrasevic A, Francetic I, Coenen S, Goossens H, and the ESAC group. Outpatient use of systemic antibiotics in Croatia. Pharm World Sci 2006;28(1):39-40.
  • Ferech M, Coenen S, Malhotra-Kumar S, Dvorakova K, Hendrickx E, Suetens C, et al. European Surveillance of Antimicrobial Consumption: Outpatient antibiotic use in Europe. J Antimicrob Chemother 2006;58(2):401-7.
  • Ferech M, Coenen S, Dvorakova K, Hendrickx E, Suetens C, Goossens H, et al. European Surveillance of Antimicrobial Consumption: Outpatient penicillin use in Europe. J Antimicrob Chemother 2006;58(2):408-12.
  • Ferech M, Coenen S, Malhotra-Kumar S, Dvorakova K, Hendrickx E, Suetens C, et al. European Surveillance of Antimicrobial Consumption: outpatient quinolone use in Europe. J Antimicrob Chemother 2006;58(2):423-7.
  • Goossens H, on behalf of the European Surveillance of Antimcirobial Consumption (ESAC) Project Group. Hospital consumption of antibiotics in 15 European countries: results of the ESAC Retrospective Data Collection (1997–2002). J Antimicrob Chemother 2006;58(4): 901-2.
  • Goossens H, Guillemot D, Ferech M, Schlemmer B, Costers M, van Breda M, et al. National campaigns to improve antibiotic use. Eur J Clin Pharmacol 2006;62(5):373-9. 
  • Vander Stichele RH, Elseviers MM, Ferech M, Blot S, Goossens H, and the ESAC Project Group. Hospital consumption of antibiotics in 15 European countries. Results of the ESAC Retrospective Data Collection (1997-2002). J Antimicrob Chemother 2006;58(1):159-67.

2005

  • Coenen S, Monnet DL, Ferech M, Goossens H, and the ESAC Project Group. Rapid response from BMJ.COM. BMJ USA 2005;5:512(E397).
  • Goossens H, Ferech M, Vander Stichele R, Elseviers M, and the ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005;365(9459):579-87.

2004

  • Vander Stichele RH, Elseviers MM, Ferech M, Blot S, Goossens H and the ESAC Project Group. European surveillance of antimicrobial consumption (ESAC): data collection performance and methodological approach.Br J Clin Pharmacol 2004;58: 419-28.
© European Centre for Disease Prevention and Control (ECDC) 2005 - 2017